Homology analysis between clinically isolated extraintestinal and enteral Klebsiella pneumoniae among neonates

Chun-mei Chen; Min Wang; Xian-ping Li; Peng-ling Li; Jing-jing Tian; Kan Zhang; Can Luo

doi:10.1186/s12866-020-02073-2

BMC Microbiology

Table 1 Clinical characteristics of the Klebsiella pneumoniae isolates

From: Homology analysis between clinically isolated extraintestinal and enteral Klebsiella pneumoniae among neonates

Case	Sex	Age	Ward	Diagnosis	Antimicrobial therapy	Use time of antibiotic	Clinical outcome	Isolates	Sample
Patient 1	M	15 days	Neonate	Premature infant HIE	MSU, MOX, MEM		Unchanged	K1	Blood
						15 days		K2	Sputum
								K3	Feces
Patient 2	M	15 days	Neonate	Premature infant HIE	MSU, CAZ, MOX	24 days	Improvement	K4	Sputum
Patient 2	M	15 days	Neonate	Premature infant HIE	MSU, CAZ, MOX	24 days	Improvement	K5	Feces
Patient 3	M	0 days	Neonate	Respiratory failure	MSU, CAZ, MEM, MOX	50 days	Improvement	K6 K7	Sputum Feces
Patient 4	F	4 days	Neonate	Neonatal pneumonia	MSU, MOX, MEM	56 days	Improvement	K8 K9	Sputum Feces
Patient 5	M	0 days	Neonate	Acute bronchopneumonia	MSU, CAZ, MEM, TZP	75 days	Improvement	K10 K11	Sputum Faces
Patient 6	M	0 days	Neonate	Neonatal encephalopathy	MSU, CAZ, MEM	13 days	Improvement	K12 K13	Sputum Feces
Patient 7	M	0 days	Neonate	Neonatal encephalopathy	MSU, CTF, MEM	13 days	Improvement	K14 K15	Sputum Feces
Patient 8	M	0 days	Neonate	Neonatal pneumonia	MSU, TZP, MEM	16 days	Improvement	K16 K17	Blood Feces
Patient 9	M	0 days	Neonate	Respiratory failure	MSU, TZP, MEM	45 days	Improvement	K18 K19	Sputum Feces
Patient10	M	0 days	Neonate	Neonatal encephalopathy	MSU, TZP, CTF	42 days	Improvement	K20 K21	Sputum Feces
Patient11	M	0 days	Neonate	Neonatal pneumonia	MSU, TZP, CTF, MEM, CAZ	42 days	Improvement	K22 K23	Sputum Feces
Patient12	F	6 days	Neonate	Neonatal pneumonia	MSU, TZP, CTF, MEM	42 days	Improvement	K24 K25	Sputum Feces
Patient13	M	10 days	Neonate	Neonatal pneumonia	MSU, TZP, MEM	29 days	Improvement	K26 K27	Sputum Feces
Patient14	M	5 days	Neonate	Neonatal pneumonia	MSU, CTF, MEM	51 days	Improvement	K28 K29	Sputum Feces
Patient15	F	25 days	Neonate	Neonatal pneumonia	MSU, MOX, CAZ, MEM	41 days	Improvement	K30 K31	Sputum Feces
Patient16	M	0 days	Neonate	Neonatal pneumonia	MSU, TZP, MEM, MOX	51 days	Improvement	K32 K33	Sputum Feces
Patient17	M	30 days	Neonate	Neonatal pneumonia	MSU, CTF, MEM	24 days	Improvement	K34 K35	Sputum Feces
Patient18	M	0 days	Neonate	Respiratory failure	MSU, CAZ, TZP, MEM	31 days	Improvement	K36 K37	Sputum Feces
Patient19	M	17 days	Neonate	Respiratory failure	MSU, CAZ	48 days	Improvement	K38 K39	Sputum Feces
Patient20	M	20 days	Neonate	Respiratory failure	CAZ, TZP, SCF	48 days	Improvement	K40 K41	Sputum Feces
Patient21	M	7 days	Neonate	Respiratory failure	MSU, SCF	11 days	Improvement	K42 K43	Sputum Feces

M male; F female; MSU mezlocillin/sulbactam; MOX moxalactam; MEM meropenem; CAZ ceftazidime; TZP piperacillin/tazobactam. CTF cefotiam; SCF cefperazone/sulbactam

Back to article page

ISSN: 1471-2180

Contact us

Submission enquiries: bmcmicrobiology@biomedcentral.com
General enquiries: ORSupport@springernature.com

You are viewing the site in preview mode

BMC Microbiology

Contact us